Started with a productive partnership as an exclusive distributor for the vascular and neurovascular division with EV3 in 2006, which was later acquired by Covidien in 2010 and afterwards by Medtronic in 2014, El Ahlyia has been able within a short period of time to achieve exceptional success in the Egyptian market with 40% annual growth. We offer 24/7 delivery of implants for stroke management cases.
Thanks to the collaborated efforts and strong commitment of our expert team, El Ahlyia has been able to maintain an excellent growth momentum and market share that have continued to uphold even through the turmoil of the political and economic instabilities. Since 2017, El Ahlyia has chosen to put its focus solely on Medtronic Neuro Intervention, choosing to seize operation in Medtronic Peripheral Vascular business.
Thanks to the collaborated efforts and strong commitment of our expert team, El Ahlyia has been able to maintain an excellent growth momentum and market share that have continued to uphold even through the turmoil of the political and economic instabilities. Since 2017, El Ahlyia has chosen to put its focus solely on Medtronic Neuro Intervention, choosing to seize operation in Medtronic Peripheral Vascular business.
